J. Biol. Chem., Vol. 261, Issue 24, 11071-11076, Aug, 1986
Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3- phosphocholine-induced fibrinogen binding to human platelets
E Kloprogge, M Mommersteeg and JW Akkerman
Platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3- phosphocholine
(PAF-acether) triggers exposure of fibrinogen binding sites on platelets
via binding to specific receptors. Comparison of [3H]PAF-acether binding
with 125I-fibrinogen binding shows that the rate with which PAF-acether
binds to a number of receptors and not the degree of receptor occupancy
determines how much fibrinogen binds. At low concentrations of PAF-acether
(0.1-1.0 nM) binding site exposure is incomplete and parallels the rate of
formation of the PAF-acether- receptor complex. Fibrinogen binding then
primarily depends on the concentration of PAF-acether. At a high
concentration of PAF-acether (500 nM) binding site exposure is complete
within 2-5 min. Fibrinogen binding then depends on the concentration of
fibrinogen. Exposure of binding sites in the absence of fibrinogen leads to
disappearance of accessible binding sites. At 500 nM PAF-acether, this
disappearance is exponential in nature and shows the same characteristics
after 5-15 min incubation with fibrinogen as after 60 min. Exposure of
binding sites is then complete within 5 min and their disappearance is not
disturbed by other processes. At 0.5 nM PAF-acether, the same
characteristics are found after 60 min incubation with fibrinogen, but
shorter incubation times reveal an ongoing binding site exposure that
interferes with the disappearance process. These results demonstrate close
coupling between the PAF-acether receptors and fibrinogen binding sites and
indicate that the rate of formation of the PAF-acether-receptor complex is
a major factor in the regulation of binding site exposure.